This brand name is authorized in Ecuador, Spain, Finland, United States
The drug ORACEA contains one active pharmaceutical ingredient (API):
|
1
Doxycycline
UNII N12000U13O - DOXYCYCLINE
|
|
Doxycycline is primarily bacteriostatic and is believed to exert its antimicrobial effect by the inhibition of protein synthesis. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J01AA02 | Doxycycline | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 2692-MEE-0517 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 73622 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 029800 |
| Country: US | FDA, National Drug Code | Identifier(s): 0299-3822 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
